254 related articles for article (PubMed ID: 25374674)
1. Advances in treating acute myeloid leukemia.
Showel MM; Levis M
F1000Prime Rep; 2014; 6():96. PubMed ID: 25374674
[TBL] [Abstract][Full Text] [Related]
2. Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
Hatzimichael E; Georgiou G; Benetatos L; Briasoulis E
Am J Blood Res; 2013; 3(1):29-51. PubMed ID: 23358589
[TBL] [Abstract][Full Text] [Related]
3. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
4. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
[TBL] [Abstract][Full Text] [Related]
5. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
6. Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Harada K; Konuma T; Machida S; Mori J; Aoki J; Uchida N; Ohashi K; Fukuda T; Tanaka M; Ikegame K; Ozawa Y; Iwato K; Eto T; Onizuka M; Ichinohe T; Atsuta Y; Yano S
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1730-1743. PubMed ID: 31054982
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
8. Myeloid progenitors in remission bone marrow in patients with malignant blood diseases: clues for slow hematopoietic regeneration after ABMT?
Hokland P; Nielsen B; Ellegaard J; Palshof T; Hokland M
J Hematother; 1996 Jun; 5(3):279-88. PubMed ID: 8817395
[TBL] [Abstract][Full Text] [Related]
9. Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development.
Yao Y; Li F; Huang J; Jin J; Wang H
Exp Hematol Oncol; 2021 Jul; 10(1):39. PubMed ID: 34246314
[TBL] [Abstract][Full Text] [Related]
10. CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Cui Q; Qian C; Xu N; Kang L; Dai H; Cui W; Song B; Yin J; Li Z; Zhu X; Qu C; Liu T; Shen W; Zhu M; Yu L; Wu D; Tang X
J Hematol Oncol; 2021 May; 14(1):82. PubMed ID: 34034795
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.
Tang FF; Huang XJ; Zhang XH; Chen H; Chen YH; Han W; Chen Y; Wang FR; Wang Y; Wang JZ; Yan CH; Sun YQ; Mo XD; Liu KY; Xu LP
Leuk Res; 2016 Aug; 47():8-15. PubMed ID: 27239735
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia.
Stone RM; O'Donnell MR; Sekeres MA
Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
[TBL] [Abstract][Full Text] [Related]
13. Brazilian guidelines on hematopoietic stem cell transplantation in acute myeloid leukemia.
Silla L; Dulley F; Saboya R; Kerbauy F; de Moraes Arantes A; Pezzi A; Gross LG; Paton E; Hamerschlak N
Eur J Haematol; 2017 Feb; 98(2):177-183. PubMed ID: 27621140
[TBL] [Abstract][Full Text] [Related]
14. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges.
Shallis RM; Wang R; Davidoff A; Ma X; Zeidan AM
Blood Rev; 2019 Jul; 36():70-87. PubMed ID: 31101526
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification.
Kansal R
Cancer Biol Med; 2016 Mar; 13(1):41-54. PubMed ID: 27144061
[TBL] [Abstract][Full Text] [Related]
18. Advances in understanding the biology and genetics of acute myelocytic leukemia.
McKenzie SB
Clin Lab Sci; 2005; 18(1):28-37. PubMed ID: 15747784
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis.
Helbig G; Koclęga A; Woźniczka K; Kopera M; Kyrcz-Krzemień S
Pathol Oncol Res; 2018 Jul; 24(3):469-475. PubMed ID: 28660547
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for acute myeloid leukemia: A review.
Kassim AA; Savani BN
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):245-251. PubMed ID: 28666104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]